This paper addresses two questions: What policies could reduce the projected growth of health spending while enhancing population health and the quality of health care? How much difference might these policies make if successfully executed? We find that depending on the costs of new treatments, biomedical innovation may place upward pressure on health spending, while increasing the length of healthy lives.
We examine three complementary strategies for avoiding wasteful spending linked to inefficiencies in health care delivery, lack of market competition, and poor population health. One is reforming provider payment systems by moving away from rewarding volume of service toward rewarding measurable value. Another is enhancing competition to increase consumer incentives to choose cost-effective treatments and providers and also to choose health plans that have more efficient payment and benefit design. A third is enhancing a culture of health by providing incentives for healthy behaviors and shifting the emphasis of providers and communities toward prevention and enabling healthy living. We identify successful examples of each and, based on preliminary and incomplete evidence, provide illustrative simulations of possible changes in health spending associated with successful implementation of a range of policies. We conclude that, while several approaches are promising, a major sustained effort is needed to identify, evaluate, and implement reinforcing policies that will restrain the growth in spending while improving population health.
Todd Stern speaks at The Economist’s Climate Risks Summit.